Skip to main content

Day: January 26, 2022

Brascan Announces Listing on Frankfurt Exchange

VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) — Brascan Gold Inc. (CSE: BRAS) (“Brascan” or the “Company“) is pleased to announce that its common shares have commenced trading on the Frankfurt Exchange under the symbol “5ZT” (the “Listing“). A listing on the Frankfurt Exchange provides companies with access to millions of international investors. The Frankfurt Exchange ranks third in terms of volume of shares traded, behind the New York Stock Exchange and the NASDAQ. The Frankfurt Exchange is the twelfth largest exchange in the world and the largest in Europe by market capitalization. A copy of the Company’s Prospectus is available under the Company’s profile at www.SEDAR.com. The Company is also announcing that Mr. Permjeet Chattu, Vice President, Brascan Gold, is resigning from his position. Balbir Johal, Director...

Continue reading

Brascan Gold Activates Earn-in Option on the Alegre Gold Project in Northeastern Brazil

Figure 1Location of the Alegre Gold ProjectFigure 2Location of the Alegre Gold Project property (yellow) between Goldmining’s Cachoeira Gold Project (green) to the north, and OZ Minerals’ CentroGold Project to the south, within the same structurally deformed volcaniclastic stratigraphic unit.Figure 3Gold garimpo of significant scale on the Alegre property.VANCOUVER, British Columbia., Jan. 25, 2022 (GLOBE NEWSWIRE) — Brascan Gold Inc. (CSE: BRAS) (“Brascan” or the “Company”) is pleased to announce formal activation of the Alegre Gold Project (the “Project”) earn-in option agreement in Pará State in northeastern Brazil. Brascan can now begin exploration of the highly prospective Alegre Gold Property. Location of the Alegre Gold Project:https://www.globenewswire.com/NewsRoom/AttachmentNg/876f6161-d3d5-4399-bd31-61b59e154469 Brascan...

Continue reading

Mainz Biomed Announces Pricing of Follow-on Offering

BERKELEY, Calif. and MAINZ, Germany, Jan. 26, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the pricing of its underwritten public follow-on offering (the “Follow-on Offering”) of 1,500,000 ordinary shares at a public offering price of US$15.00 per ordinary share (the “Offering Price”), for gross proceeds of $22,500,000. The Follow-on Offering is being made pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”). The Follow-on Offering is expected to close on January 28, 2022, subject to the satisfaction of customary closing conditions. In connection with the Follow-on Offering, Mainz Biomed has granted the underwriter the option...

Continue reading

Randolph Bancorp, Inc. Announces Fourth Quarter 2021 Financial Results and Declares Quarterly and Special Cash Dividends

QUINCY, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) — Randolph Bancorp, Inc. (NASDAQ: RNDB) Randolph Bancorp, Inc. (the “Company”) (NASDAQ Global Market: RNDB), the holding company for Envision Bank (the “Bank”), today announced net income of $786,000, or $0.17 per basic share and $0.16 per diluted share, for the three months ended December 31, 2021 compared to net income of $3.1 million, or $0.64 per basic and $0.62 per diluted share, for the three months ended September 30, 2021 and net income of $5.3 million, or $1.03 per basic share and $1.01 per diluted share, for the three months ended December 31, 2020. Excluding one-time events of $26,000 in severance expenses and $55,000 in loss of disposal of fixed assets, net income on a non-GAAP basis was $844,000, or $0.17 per diluted share, for the three months ended December 31, 2021....

Continue reading

QNB Corp. Reports Earnings for Fourth Quarter 2021

QUAKERTOWN, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) — QNB Corp. (the “Company” or “QNB”) (OTC Bulletin Board: QNBC), the parent company of QNB Bank (the “Bank”), reported net income for the fourth quarter of 2021 of $4,149,000, or $1.17 per share on a diluted basis. This compares to net income of $4,151,000, or $1.17 per share on a diluted basis, for the same period in 2020. For the year ended December 31, 2021, QNB reported net income of $16,492,000, or $4.64 per share on a diluted basis. This compares to net income of $12,083,000, or $3.42 per share on a diluted basis, reported for the same period in 2020. For the quarter ended December 31, 2021, the annualized rate of return on average assets and average shareholders’ equity was 0.98% and 11.82%, respectively, compared with 1.16% and 12.95%, respectively, for the fourth quarter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.